Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $0.4.

  • Acadia Healthcare Company's EPS (Weighted Average and Diluted) fell 4594.59% to $0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.18, marking a year-over-year decrease of 6131.15%. This contributed to the annual value of $2.78 for FY2024, which is 125833.33% up from last year.
  • According to the latest figures from Q3 2025, Acadia Healthcare Company's EPS (Weighted Average and Diluted) is $0.4, which was down 4594.59% from $0.33 recorded in Q2 2025.
  • Acadia Healthcare Company's 5-year EPS (Weighted Average and Diluted) high stood at $0.88 for Q2 2022, and its period low was -$2.39 during Q3 2023.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.67 (2022), whereas its average is $0.45.
  • Per our database at Business Quant, Acadia Healthcare Company's EPS (Weighted Average and Diluted) surged by 16800.0% in 2022 and then tumbled by 40641.03% in 2023.
  • Acadia Healthcare Company's EPS (Weighted Average and Diluted) (Quarter) stood at $0.77 in 2021, then fell by 12.99% to $0.67 in 2022, then decreased by 5.97% to $0.63 in 2023, then plummeted by 42.86% to $0.36 in 2024, then rose by 11.11% to $0.4 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.4 for Q3 2025, versus $0.33 for Q2 2025 and $0.09 for Q1 2025.